NovoCure NVCR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Geography | ||||||
| France | $81.21M+28.7% | $76.19M+36.7% | $71.63M+50.5% | $67.25M+84.3% | $63.1M+184% | |
| Germany | $85.19M+24.9% | $79.41M+21.7% | $75.51M+20.8% | $72.21M+20.0% | $68.23M+12.2% | |
| Greater China | $19.62M+15.0% | $19.44M+11.8% | $16.78M-15.3% | $15.81M-27.9% | $17.07M-25.3% | |
| Japan | $39.32M+17.5% | $37.79M+16.0% | $36.09M+14.1% | $35.28M+15.2% | $33.46M+8.6% | |
| Other international markets | $60.64M+33.5% | $56.9M+34.0% | $51.04M+26.6% | $46.65M+26.4% | $45.44M+34.1% | |
| United States | $388.43M-1.5% | $385.63M-1.6% | $391.23M+4.1% | $392.96M+8.0% | $394.41M+11.1% | |
| Total long lived assets by Geography | ||||||
| Israel | $126.87M+162% | $128.86M+212% | $130.92M+291% | $89.49M+170% | $48.38M+49.4% | |
| Switzerland | $123.97M+14.6% | $127.92M+86.4% | $106.81M+116% | $109.52M+184% | $108.21M+248% | |
| United States | $263.18M+14.0% | $261.1M+23.2% | $258.33M+35.5% | $246.27M+40.2% | $230.81M+43.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does NovoCure break its business down?
- NovoCure (NVCR) reports net revenues by geography across 6 parts — France, Germany, Greater China, Japan and Other international markets. Each is extracted from the segment footnotes and tracked over time.
- Where does NovoCure's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in NovoCure's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
